These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28370570)

  • 1. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy.
    de Ridder M; Klop M; Hamming-Vrieze O; de Boer J; Jasperse B; Smit L; Vogel W; van den Brekel M; Al-Mamgani A
    Head Neck; 2017 Jul; 39(7):1382-1391. PubMed ID: 28370570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of
    Berwouts D; Madani I; Duprez F; Olteanu AL; Vercauteren T; Boterberg T; Deron P; Bonte K; Huvenne W; De Neve W; Goethals I
    Head Neck; 2017 Nov; 39(11):2264-2275. PubMed ID: 28833829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative cohort study of volumetric modulated arc therapy for squamous cell cancer of unknown primary in the head and neck-Involved neck only versus mucosal irradiation.
    Poon WY; Thomson M; McLoone P; Wilson C; Crosbie R; Schipani S; Grose D; James A; Lamb C; Rizwanullah M; Campbell F; Easton F; Paterson C
    Clin Otolaryngol; 2020 Nov; 45(6):847-852. PubMed ID: 32501648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of 18FDG-PET/CT in the management and gross tumor volume definition for radiotherapy of head and neck cancer; single institution experiences based on long-term follow-up].
    Hideghéty K; Cserháti A; Besenyi Z; Zag L; Gaál S; Együd Z; Mózes P; Szántó E; Csenki M; Rusz O; Varga Z; Dobi Á; Maráz A; Pávics L; Lengyel Z
    Magy Onkol; 2015 Jun; 59(2):103-10. PubMed ID: 26035157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.
    Richards TM; Bhide SA; Miah AB; Del Rosario L; Bodla S; Thway K; Gujral DM; Rooney KP; Schick U; McGovern T; Grove L; Newbold KL; Harrington KJ; Nutting CM
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e77-e84. PubMed ID: 27180092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
    Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
    Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity modulated arc therapy implementation in a three phase adaptive (18)F-FDG-PET voxel intensity-based planning strategy for head-and-neck cancer.
    Berwouts D; Olteanu LA; Speleers B; Duprez F; Madani I; Vercauteren T; De Neve W; De Gersem W
    Radiat Oncol; 2016 Apr; 11():52. PubMed ID: 27039294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography as an effective diagnostic workup in cervical metastasis of carcinoma from an unknown primary tumor.
    Zhao K; Luo XM; Zhou SH; Liu JH; Yan SX; Lu ZJ; Yang SY; Lin LL; Dong MJ
    Cancer Biother Radiopharm; 2012 Dec; 27(10):685-93. PubMed ID: 22834634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy.
    Kamal M; Mohamed ASR; Fuller CD; Sturgis EM; Johnson FM; Morrison WH; Gunn GB; Hutcheson KA; Phan J; Volpe S; Ng SP; Ferrarotto R; Frank SJ; Skinner HD; Rosenthal DI; Garden AS
    Cancer; 2018 Apr; 124(7):1415-1427. PubMed ID: 29338089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term results of postoperative Intensity-Modulated Radiation Therapy (IMRT) in the treatment of Squamous Cell Carcinoma (SCC) located in the oropharynx or oral cavity.
    Hoffmann M; Saleh-Ebrahimi L; Zwicker F; Haering P; Schwahofer A; Debus J; Huber PE; Roeder F
    Radiat Oncol; 2015 Dec; 10():251. PubMed ID: 26637471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved dosimetric and clinical outcomes with intensity-modulated radiotherapy for head-and-neck cancer of unknown primary origin.
    Chen AM; Li BQ; Farwell DG; Marsano J; Vijayakumar S; Purdy JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):756-62. PubMed ID: 20421143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
    Dale E; Moan JM; Osnes TA; Bogsrud TV
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.